An Epidemiological Study Incidence Rates of Risk Factors for Colorectal Cancer's Early Symptoms in the Community in Gondanglegi District, Malang, East Java, Indonesia: An Epidemiological Study
DOI:
https://doi.org/10.26911/jepublichealth.2024.09.02.12Abstract
Background: Colorectal cancer (CRC) is one of the most common types of cancer worldwide. CRC is most typical symptom is hematochezia while the risk factors encompass sex, age, genetic predispositions, history of colorectal polyps or cancer, chronic inflammatory bowel diseases, physical exercise, and specific dietary choices, including high red meat intake, fried food, and low fiber consumption. This study aims to screen the risk factors of colorectal cancer.
Subjects and Method: This research was conducted on residents in the Sepanjang village, Malang Regency, involved in community service by the Internist Association of Malang. Community service was carried out in July 2023 and 148 residents were involved in collecting data on risk factors for colorectal carcinoma. Data collection was carried out using a questionnaire with a cross-sectional approach. The questionnaire assesses the presence of symptoms of bloody stools and several habits related to colorectal carcinoma risk factors, including age, gender, exercise routine, and dietary history. Data presentation and analysis were carried out as in the table.
Results: Among the risk factors listed assessed using the questionnaire, Men (p=0.021), lack of exercise (p= 0.008), consumption of fried food (p= 0.021), and consumption of instant noodles (p= 0.013) significantly affect the prevalence of hematochezia.
Conclusion: Men, lack of exercise, consumption of fried food, and consumption of instant noodles significantly affect the hematochezia indicating CRC.
Keywords:
Colorectal carcinoma, risk factor, lack of exercise, fried foodReferences
Amirsasan R, Akbarzadeh M, Akbarzadeh S (2022). Exercise and colorectal cancer: prevention and molecular mechanisms. Cancer Cell Int. 22(1): 1–22. doi:10.1186/s12935-022-02670-3.
Budianto A, Andarini S, Hariyanti T, Muslihah N (2023). Exploring the Correlation Between Ethnicity and Health-Seeking Behavior for Colorectal Cancer in East Java, Indonesia: A Case Study of Arek, Mataraman, and Pendalungan Ethnic Groups. Asian Pac J Cancer Prev. 24(6): 1931–1942. doi:10.31557/APJCP.2023.24.6.1931.
Costea T, Hudiță A, Ciolac OA, Gălățeanu B, Ginghină O, Costache M, Ganea C, et al. (2018). Chemoprevention of colorectal cancer by dietary compounds. Int J Mol Sci. 19(12). doi:10.3390/ijms19123787.
Dacrema M, Ali A, Ullah H, Khan A, Di Minno A, Xiao J, Martins AMC, et al. (2022). Spice-Derived Bioactive Com-pounds Confer Colorectal Cancer Prevention via Modulation of Gut Micro-biota. Cancers. 14(22). doi: 10.3390/cancers14225682.
Dalal N, Jalandra R, Sharma M, Prakash H, Makharia GK, Solanki PR, Singh R, et al. (2020). Omics technologies for improved diagnosis and treatment of colorectal cancer: Technical advancement and major perspectives. Biomed Pharmacother. 131: 110648. doi: 10.1016/j.biopha.2020.110648.
Ferlizza E, Solmi R, Sgarzi M, Ricciardiello L, Lauriola M (2022). Colorectal Cancer : A Review of Carcinogenesis, Global. Cancer. 14(1732): 1–25.
Liang H, He X, Tong Y, Bai N, Pu Y, Han K, Wang Y (2023). Ferroptosis opens a new door for colorectal cancer treatment. Front oncol. 13: 1–13. doi: 10.3389/fonc.2023.1059520.
Macharia JM, Mwangi RW, Rozmann N, Zsolt K, Varjas T, Uchechukwu PO, Wagara IN, et al. (2022). Medicinal plants with anti-colorectal cancer bioactive compounds: Potential game-changers in colorectal cancer management. Biomed. Pharmacother. 153: 113383. doi: 10.1016/j.biopha.2022.113383.
Mansour-Ghanaei A, Joukar F, Mansour-Ghanaei F, Rasoulian J, Naghipour MR, Fani A, Kazemnejad E (2015). Knowledge about Colorectal cancer in Northern Iran: A population-based telephone survey. Asian Pac J Cancer Prev. 16(17): 7831–7836. doi: 10.7314/APJCP.2015.16.17.7831.
Nazha B (2015). Hypoalbuminemia in colorectal cancer prognosis: Nutritional marker or inflammatory surrogate?. orld J Gastrointest Surg. 7(12): 370. doi:10.4240/wjgs.v7.i12.370.
O'Sullivan DE, Sutherland RL, Town S, Chow K, Fan J, Forbes N, Heitman SJ., et al. (2022). Risk Factors for Early-Onset Colorectal Cancer: A Systematic Review and Meta-analysis. Clin Gastroenterol Hepatol. 20(6): 1229-1240.e5.doi:10.1016/j.cgh.2021.01.037
Oostindjer M, Alexander J, Amdam GV, Andersen G, Bryan NS, Chen D, Corpet DE., et al. (2014). The role of red and processed meat in colorectal cancer development: A perspective. Meat Sci. 97(4): 583–596. doi: 10.1016/j.meatsci.2014.02.011.
Purnomo HD, Permatadewi CO, Prasetyo A, Indiarso D, Hutami HT, Puspasari D, Listiana DE, et al. (2023). Colorectal cancer screening in Semarang, Indonesia: A multicenter primary health care based study. PLoS ONE. 18(1): 1–12. doi:10.1371/journal.pone.0279570.
Sawicki T, Ruszkowska M, Danielewicz A, Niedźwiedzka E, Arłukowicz T, Przyby-łowicz KE (2021). A review of colorectal cancer in terms of epidemiology, risk factors, development, symptoms and diagnosis. Cancers. 13(9): 1–23. doi:10.3390/cancers13092025.
Tielemans MM, Jaspers FJ, van-Rossum LG, Eikendal T, Jansen JB, Laheij RJ, van-Oijen MG (2013). Gastrointestinal symptoms are still prevalent and negatively impact health-related quality of life: A large cross-sectional population based study in the Nether-lands. PLoS ONE. 8(7). doi:10.1371/journal.pone.0069876.
Wagner, C., Cadar D., Hackett RA., Dema-kakos P., Beeken RJ., Bailey SC., Wolf M., et al. (2020). Type 2 diabetes and colorectal cancer screening: Findings from the English Longitudinal Study of Ageing. (2020). Journal of Medical Screening. 27(1): 25-30. doi: 10.1177/0969141319874834.
Downloads
Published
2024-04-16
Issue
Vol. 9 No. 2 (2024)
Section
Articles
1.jpg)
